AbstractThe report is based on the study of annual reports of Cipla middle of the roader and Sun Pharmaceutical Industries Limited for the five years from 2003-2004 to 2007-2008. The briny objective of this study was to apply the concepts learned as a part of this course and understand the business, monetary health and the sum up practices followed by these companies. As a part of this report we get hold of tried to analyze the current and past performance trends for the troupe and predict the future performance and stock prices of the company. To achieve this we fix analyzed Revenue Trends, Profitability, Liquidity, Debts, Stocks, Cash Flows and provided a summary at the end of the report. The scope of the report is limited to our understanding of the fiscal Statements based on the current course. The report has to be seen in its completeness along with the excel worksheet containing the past five years fiscal data of the two firms and various ratios. IntroductionCipla i s a leading pharmaceutical company in India and it is one of the largest exporters of drugs from India with exports contributing around 50% of its annual revenues. It offers a comprehensive range of products ranging from anti-asthma, cardiac to critical care drugs. Over the past 3 years the municipal revenue has grown at a rate of 12% and the export revenue at 27% . Sun Pharmaceuticals is a Mumbai based multinational company employing over 8,000 people and manufacturing facilities in 19 countries. It specializes in chronic ailment drugs and has been consistently beef up market share in India. The recent acquisitions of Caraco Pharm has helped Sun to clay sculpture up its global presence. Cipla and Sun Pharmaceuticals are comparable companies in harm of revenues and profits which makes it easier to compare the two companies and understand the concepts of... If you sine qua non to tolerate a full essay, order it on our website: OrderCustom! Paper.com
If you want to get a full essay, visit our page: write my paper
No comments:
Post a Comment